Thirumalai Chemicals: loss steady at ₹34 Cr YoY as revenue grows 34%, margins expand
PAT -2.79% YoY · revenue +33.93% · margins expanding
₹596.47 Cr
+33.93% YoY
₹-34.31 Cr
-2.79% YoY
-5.66%
+1.7pp YoY
₹-2.85
On a consolidated basis — the primary read for this Group, which runs manufacturing through subsidiaries including the US-based TCL Specialties LLC — Thirumalai Chemicals posted revenue of ₹596.47 Cr, up 33.9% YoY from ₹445.37 Cr and up 9.1% QoQ from ₹546.67 Cr, while the net loss came in at ₹34.31 Cr, essentially flat YoY (₹33.38 Cr loss in Q2 FY26, loss widening ~2.8% in absolute rupees) but 21.4% narrower than the ₹43.67 Cr loss booked in Q1 FY27. There is no analyst consensus or brokerage preview available for this specific quarter, and the company has not issued any formal guidance on record, so neither vs-street nor vs-guidance can be assessed — both are genuinely unknown rather than omitted. No management press release accompanies this filing yet, so there is no company framing to reconcile against the numbers beyond the board outcome letter and the statutory notes.
Q2 FY-2027 vs prior quarters
The quarter's real story is a margin inflection rather than a swing to profit. Operating margin (OPM) turned positive at roughly 6.5%, improving from 5.96% last quarter and from -0.82% a year ago — the first clean operating recovery in recent quarters — while net margin improved to -5.75% from -7.94% (QoQ) and -7.36% (YoY) even though the absolute rupee loss didn't shrink YoY. The gap between a positive operating result and a continued net loss sits squarely on financing: consolidated finance costs of ₹56.66 Cr and depreciation of ₹21.89 Cr together exceed the ₹38.67 Cr EBITDA generated, and those costs trace directly to capex-driven borrowings for the Group's non-recurring US project buildout. Tellingly, standalone (parent-only) results were profitable — PAT of ₹11.65 Cr on revenue of ₹339.27 Cr — underscoring that the consolidated drag is a subsidiary-financing issue, not a core Indian-operations problem.
The stock went into the print at ₹125.85, down 15.3% over the past month of trading.
For context: PAT has now risen for 2 consecutive quarters; revenue is at a 6-quarter high.
Several corporate developments this quarter tie directly into the balance-sheet picture the notes disclose: the Group's current liabilities exceeded current assets by ₹772.69 Cr at quarter-end (attributed to TCL Specialties' capex), and management says it has engaged a top-tier investment banker to arrange $130-180 million of financing for the US project, with term sheets under evaluation and completion targeted by end-November 2026 — the auditors signed off on a going-concern basis on that strength. The quarter's stake-sale disclosure (partial disposal of Ultramarine & Pigments shares, ₹96.73 Cr proceeds) and a windmill/land sale contributed an ₹8.22 Cr one-off gain sitting inside other income, immaterial to the overall ₹606 Cr total income. Separately, the company disclosed a ₹17.31 Cr tax show-cause notice, a smaller ₹13.52 lakh tax discrepancy notice, and a ₹24.52 lakh customs/RoDTEP audit observation during the quarter — none of these are booked as expenses yet and are disclosed as contingent matters, not P&L drivers. This is also the first quarter reviewed by a new statutory auditor (PKF Sridhar & Santhanam LLP), with the predecessor auditor's reports covering the comparative periods.
W1
Closure of the $130-180 million TCL Specialties LLC financing, which management targets by end-November 2026 — would start easing the ₹56.66 Cr quarterly finance-cost drag
W2
Whether the OPM recovery (~6.5% this quarter vs -0.82% a year ago) holds into Q3 FY27 or proves a one-quarter bounce, given no formal guidance on record
W3
Resolution of the ₹17.31 Cr tax show-cause notice and other contingent tax/customs matters disclosed this quarter, none yet booked as expenses